SARS-CoV

SARS-CoV

货号 产品名 CAS号 信息
FB20384 SSAA09E2 883944-52-3 SSAA09E2 is a novel inhibitor of SARS-CoV replication, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV, Angiotensin Converting Enzyme-2 (ACE2).
FB02250 PLpro Inhibitor 1093070-14-4 PLpro inhibitor is a potent inhibitor of papain-like protease (PLpro) with IC50 of 2.6 μM.
FB16757 EIDD-2801   2349386-89-4 EIDD-2801 is an orally bioavailable prodrug of EIDD-1931, which has a broad-spectrum antiviral activity against 39 multiple coronaviruses, including SARS-CoV2, MERS-CoV, SARS-CoV. and related zoonotic group 2b or 2c Bat-CoVs, as well as increased potency against a coronavirus bearing resistance mutations to another nucleoside analog inhibitor.
FB16758 EIDD-1931 3258-02-4 EIDD-1931 has a broad-spectrum antiviral activity against multiple coronaviruses, including SARS-CoV2, MERS-CoV, SARS-CoV. and related zoonotic group 2b or 2c Bat-CoVs, as well as increased potency against a coronavirus bearing resistance mutations to another nucleoside analog inhibitor.
FB16677 6-Chloro-3-hydroxypyrazine-2-carboxamide 259793-90-3 6-Chloro-3-hydroxypyrazine-2-carboxamide is an intermediate for favipiravir.
FB16684 6-Bromo-3-hydroxypyrazine-2-carboxamide 259793-88-9 6-Bromo-3-hydroxypyrazine-2-carboxamide is an intermediate for favipiravir.
FB16679 4'-O-Methylbroussochalcone B 20784-60-5 4'-O-Methylbavachalcone is a chalcone isolated from Psoralea corylifolia, which can inhibit severe acute respiratory syndrome coronavirus (SARS-CoV) papain-like protease (PLpro) activity, with an IC50 of 10.1 μM
<< 上一页 1 下一页 >>
联系
我们